157 related articles for article (PubMed ID: 22992624)
1. Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
Charlton ME; Lin C; Jiang D; Stitzenberg KB; Halfdanarson TR; Pendergast JF; Chrischilles EA; Wallace RB
Am J Clin Oncol; 2013 Dec; 36(6):572-9. PubMed ID: 22992624
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.
Enker WE; Merchant N; Cohen AM; Lanouette NM; Swallow C; Guillem J; Paty P; Minsky B; Weyrauch K; Quan SH
Ann Surg; 1999 Oct; 230(4):544-52; discussion 552-4. PubMed ID: 10522724
[TBL] [Abstract][Full Text] [Related]
3. Temporal and regional variations in the use of preoperative radiation therapy for rectal cancer.
Lin C; Charlton ME; Meza JL; Enke CA; Loberiza FR
Am J Clin Oncol; 2010 Oct; 33(5):443-7. PubMed ID: 19952718
[TBL] [Abstract][Full Text] [Related]
4. Preoperative "chemoradiation" for stages II and III rectal carcinoma.
Stryker SJ; Kiel KD; Rademaker A; Shaw JM; Ujiki GT; Poticha SM
Arch Surg; 1996 May; 131(5):514-8; discussion 518-9. PubMed ID: 8624198
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
[TBL] [Abstract][Full Text] [Related]
6. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
7. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
8. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
[TBL] [Abstract][Full Text] [Related]
9. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
Song C; Song S; Kim JS; Oh HK; Kim DW; Lee KW; Kim JH; Eom KY; Kim IA; Kang SB
PLoS One; 2015; 10(4):e0123657. PubMed ID: 25902069
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
White RR; Kattan MW; Haney JC; Clary BM; Pappas TN; Tyler DS; Brennan MF
Ann Surg Oncol; 2006 Nov; 13(11):1485-92. PubMed ID: 17013688
[TBL] [Abstract][Full Text] [Related]
11. Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration.
Spiegel DY; Boyer MJ; Hong JC; Williams CD; Kelley MJ; Moore H; Salama JK; Palta M
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):565-573. PubMed ID: 30359718
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation.
Kang J; Hur H; Min BS; Lee KY; Kim NK
J Surg Oncol; 2011 Jul; 104(1):53-8. PubMed ID: 21416471
[TBL] [Abstract][Full Text] [Related]
13. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
14. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
[TBL] [Abstract][Full Text] [Related]
15. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer.
Tural D; Selcukbiricik F; Yıldız Ö; Elcin O; Erdamar S; Güney S; Demireli F; Büyükünal E; Serdengeçti S
Int J Clin Oncol; 2014 Oct; 19(5):889-96. PubMed ID: 24218281
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results.
Guimas V; Boustani J; Schipman B; Lescut N; Puyraveau M; Bosset JF; Servagi-Vernat S
Drugs Aging; 2016 Jun; 33(6):419-25. PubMed ID: 27138958
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.
Schrag D; Weiser MR; Goodman KA; Gonen M; Hollywood E; Cercek A; Reidy-Lagunes DL; Gollub MJ; Shia J; Guillem JG; Temple LK; Paty PB; Saltz LB
J Clin Oncol; 2014 Feb; 32(6):513-8. PubMed ID: 24419115
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial.
Garcia-Aguilar J; Smith DD; Avila K; Bergsland EK; Chu P; Krieg RM;
Ann Surg; 2011 Jul; 254(1):97-102. PubMed ID: 21494121
[TBL] [Abstract][Full Text] [Related]
19. Rectal cancer: changing patterns of referral for radiation therapy 1982-1997.
Stevens G; Firth I; Solomon M; Saw R; Glenn D; Eyers A; West R
Aust N Z J Surg; 2000 Aug; 70(8):553-9. PubMed ID: 10945546
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.
Braendengen M; Tveit KM; Berglund A; Birkemeyer E; Frykholm G; Påhlman L; Wiig JN; Byström P; Bujko K; Glimelius B
J Clin Oncol; 2008 Aug; 26(22):3687-94. PubMed ID: 18669453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
